New technique for screening breast cancer using ultrasound

New screening technique could provide more reliable breast cancer detection — Initial tests show promising results of new ultrasonic screening technique – Scientists have successfully completed an initial trial of a new, potentially more reliable, technique for screening breast cancer using ultrasound. The team at the National Physical Laboratory (NPL), the UK’s National Measurement Institute, working with the University Hospitals Bristol NHS Foundation Trust, are now looking to develop the technique into a clinical device.

CT colonography a front line colorectal cancer screening tool for seniors

A recent analysis of data collected in the National CT Colonography Trial conducted by the American College of Radiology Imaging Network confirms the efficacy of the exam as a front line colorectal cancer screening tool for seniors – Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older.

New melanoma drug doubles survival of skin cancer patients

Skin cancer drug hopes raised by study — Advanced melanoma drug nearly doubles survival time – Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.

No benefits with B vitamin, omega-3 supplements on cancer outcomes

No Benefits Associated with B Vitamin, Omega-3 Supplements on Cancer Outcomes in Those with Prior Cardiovascular Disease – Taking supplements of B vitamins and omega-3 fatty acids for cancer prevention does not appear to be beneficial for patients with prior cardiovascular disease. Proper nutrition is considered to be protective against cancer but much is unknown about the roles of individual nutrients in different populations.

4 times cancer rate in children with juvenile arthritis

Cancer rate 4 times higher in children with juvenile arthritis — Increase not necessarily linked to arthritis treatments, including TNF inhibitors – New research reports that incident malignancy among children with juvenile idiopathic arthritis (JIA) is four times higher than in those without the disease. Findings suggest JIA treatment, such as tumor necrosis factor (TNF) inhibitors, does not necessarily explain the development of cancer in this pediatric population.

Breast cancer funding restored by Komen Foundation to Planned Parenthood

Komen Foundation Restores Funding for Breast Cancer Screenings at Planned Parenthood Health Centers – The Susan G. Komen for the Cure Foundation reversed its decision and continues to fund breast cancer screenings at Planned Parenthood health centers. The outpouring of support online for Planned Parenthood and women in need of breast cancer screenings has been nothing short of astonishing, and because of it, the Planned Parenthood Breast Health Fund has received more than $3 million from thousands of people across the country in only three days.

Susan G. Komen stops funding breast cancer programs at Planned Parenthood

Susan G. Komen for the Cure Foundation decides to stop funding breast cancer prevention, screenings and education at Planned Parenthood health centers – Planned Parenthood Federation of America expressed deep disappointment in response to the Susan G. Komen for the Cure Foundation’s decision to stop funding breast cancer prevention, screenings and education at Planned Parenthood health centers.

Additional breast surgery common after partial mastectomy

Study finds substantial variability in rate of additional surgery after partial mastectomy – Nearly one in four women who undergo a partial mastectomy for treatment of breast cancer have another surgery to remove additional tissue (reexcision), and there is substantial surgeon and institutional variation in the rate of reexcisions that cannot be explained by patients’ clinical characteristics.

Erivedge approved for skin cancer metastatic basal cell carcinoma

FDA approves new treatment for most common type of skin cancer – Erivedge or vismodegib was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The Erivedge drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).

New lung cancer test could accurately guide treatment for people with lung cancer

New lung cancer test predicts survival — Clinical studies in US and China show molecular test could more accurately guide treatment for people with lung cancer – In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

Regorafenib improves survival of colorectal cancer patients

Drug improves survival of colorectal cancer patients, trial results show – Regorafenib – an investigational drug – slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer. This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia